International Patent: LP(A)-TARGETING DOUBLE-STRANDED SIRNA AGENT AND USE THEREOF

GENEVA, Sept. 18 -- SUNSHINE LAKE PHARMA CO., LTD. filed a patent application (CN2026/081274) for “LP(A)-TARGETING DOUBLE-STRANDED SIRNA AGENT AND USE THEREOF”. With publication no. WO/2026/184618, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C12N 15/113

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....